EP 2 279 254 B1 relates to novel lipid formulations for nucleic acid delivery.
Brief outline of the case
A first decision of the OD has been set aside due to a SPV under Art 113(1), cf. T 505/20.
In a second decision of the OD,
T 1166/24-On the prohibition of the reformatio in peius (PRP)
by Daniel X. Thomas